Meanwhile, c-Myc was regulated by FTO via m6A modification in HCC, which was similarity in leukemia, colorectal cancer, gastric cancer, glioma and lung adenocarcinoma [23, 43–46]. The gene discussed is MYC; the disease is hepatocellular carcinoma.